Clinical characteristics of 119 patients with myelodysplastic syndromes
| Characteristics . | Patients, n (%) . |
|---|---|
| Sex | |
| Male | 55 (46) |
| Female | 64 (54) |
| Median age, y (range) | 61 (20-90) |
| Median follow-up, mo (range) | 46 (1-236) |
| WHO classification | |
| RA | 22 (19) |
| RCMDnc | 34 (29) |
| RCMDac | 17 (14) |
| RARS | 12 (10) |
| RCMD-RS | 12 (10) |
| 5q− syndrome | 16 (13) |
| RAEB | 6 (5)* |
| IPSS | |
| Low risk | 70 (64) |
| Int-1 | 33 (30) |
| Int-2 | 3 (3) |
| High | 3 (3) |
| Unavailable | 10 (8) |
| Cytogenetics | |
| Normal | 77 (65) |
| Isolated del(5q) | 21 (18) |
| Del(5q) + additional cytogenetic changes | 15 (12) |
| Unavailable | 6 (5) |
| Characteristics . | Patients, n (%) . |
|---|---|
| Sex | |
| Male | 55 (46) |
| Female | 64 (54) |
| Median age, y (range) | 61 (20-90) |
| Median follow-up, mo (range) | 46 (1-236) |
| WHO classification | |
| RA | 22 (19) |
| RCMDnc | 34 (29) |
| RCMDac | 17 (14) |
| RARS | 12 (10) |
| RCMD-RS | 12 (10) |
| 5q− syndrome | 16 (13) |
| RAEB | 6 (5)* |
| IPSS | |
| Low risk | 70 (64) |
| Int-1 | 33 (30) |
| Int-2 | 3 (3) |
| High | 3 (3) |
| Unavailable | 10 (8) |
| Cytogenetics | |
| Normal | 77 (65) |
| Isolated del(5q) | 21 (18) |
| Del(5q) + additional cytogenetic changes | 15 (12) |
| Unavailable | 6 (5) |
Four patients had transformed from 5q− syndrome and 2 from RARS.